ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity

Author： Ait-Tihyaty Maria   Rachid Zakaria   Larroque-Lombard Anne-Laure   Jean-Claude Bertrand  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.31, Iss.6, 2013-12, pp. : 1409-1423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vitro and In Vivo Biodistribution of ZRS1, a Stabilized Type I N-Acetoxymethyl Carbamate-Containing Combi-Molecule

By  

Drug Metabolism Letters, Vol. 5, Iss. 2, 2011-04 ,pp. : 141-149

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear receptor-mediated regulation of carboxylesterase expression and activity

By Staudinger Jeff L   Xu Chenshu   Cui Yue J   Klaassen Curtis D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 261-271

Informa Healthcare

Access to resources Recommend Favorite

Small Molecules with EGFR-TK Inhibitor Activity

By  

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 259-274

Bentham Science Publishers

Access to resources Recommend Favorite

A Carboxylesterase 2 Gene Polymorphism as Predictor of Capecitabine on Response and Time to Progression

By  

Current Drug Metabolism, Vol. 9, Iss. 4, 2008-05 ,pp. : 336-343

Bentham Science Publishers

Access to resources Recommend Favorite

Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-02 ,pp. : 427-8

Bentham Science Publishers

Access to resources Recommend Favorite